Systemic bioavailability of hydrofluoroalkane formulations containing fluticasone propionate and salmeterol

Lignende værker

• Systemic bioavailability of hydrofluoroalkane formulations containing fluticasone and salmeterol: a reply
  af: Lipworth, Brian J, et al.
  Udgivet: (2011)
• Systemic bioavailability of fluticasone propionate administered as nasal drops and aqueous nasal spray formulations
  af: Daley-Yates, Peter T, et al.
  Udgivet: (2001)
• Systemic bioavailability of hydrofluoroalkane (HFA) formulations of fluticasone/salmeterol in healthy volunteers via pMDI alone and spacer
  af: Clearie, Karine L, et al.
  Udgivet: (2010)
• Safety and Efficacy of Fluticasone Propionate/Salmeterol Hydrofluoroalkane 134a Metered-Dose-Inhaler Compared with Fluticasone Propionate/Salmeterol Diskus in Patients with Chronic Obstructive Pulmonary Disease
  af: Koser, Andras, et al.
  Udgivet: (2010)
• Dose–response for adrenal suppression with hydrofluoroalkane formulations of fluticasone propionate and beclomethasone dipropionate
  af: Fowler, Stephen J, et al.
  Udgivet: (2001)